CellCentric’s scientific founder awarded Royal Medal
Prof Azim Surani FRS CBE has been awarded the Royal Society’s Royal Medal for his pivotal contributions to the understanding of early mammalian development.
CellCentric key collaborator awarded FRS
Professor Wolf Reik Head of the Laboratory of Developmental Genetics and Imprinting at the Babraham Institute has been elected to the Fellowship of the Royal Society. Professor Reik is a world leading authority in the field of epigenetics.
CellCentric receives two research awards from the BBSRC
Grant funding has been gained from the Biotechnology and Biological Sciences Research Council (BBSRC) to further CellCentric’s investigation of epigenetic control mechanisms and the identification of small molecule modulators, in collaboration with Professor Wolf Reik at the Babraham Institute.
CellCentric licenses novel epigenetic discovery programme to Takeda
From its broad portfolio of novel targets in epigenetics, CellCentric has out-licensed exclusively the development and commercialisation of an important programme focused on cancer.
CellCentric heads new collaboration with Sigma-Aldrich, The Automation Partnership and leading epigenetic researchers
The University of Cambridge, UCL (University College London), CellCentric, Sigma-Aldrich and The Automation Partnership embark on a collaboration to define markers of epigenetic reprogramming, supported by £1.1m from the UK Government’s Technology Strategy Board.
CellCentric epigenetic imprint erasure factor published in Nature
New data from Prof. Wolf Reik of the Babraham Institute, Cambridge, highlights the key role of the cytidine deaminase AID in DNA demethylation and the reprogramming of cells.
CellCentric cancer target review in Drug Discovery Today
CellCentric’s Director of Exploratory Research, Nessa Carey and colleague Jonathan Best publish a review on epigenetics and oncology in Drug Discovery Today.